Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11

BackgroundIrritable Bowel Syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by symptoms such as abdominal pain, bloating, and altered bowel habits. Probiotic-based strategies are increasingly being explored for IBS management, with growing interest in strain-specific app...

Descripción completa

Detalles Bibliográficos

Autores principales:	Alexander Bertuccioli, Davide Sisti, Nadia Lazzerini, Chiara Maria Palazzi, Giordano Bruno Zonzini, Mirko Ragazzini, Annalisa Belli
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2025-05-01
Colección:	Frontiers in Medicine
Materias:	irritable bowel syndrome Clostridium butyricum CBM588 Bifidobacterium longum W11 probiotics IBS-D IBS-C
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1604319/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!